Literature DB >> 35031882

Relationships between sodium levels, haemodynamics and metalloproteinases in heart failure patients.

Tetsuji Morishita1,2,3, Hiroyasu Uzui4, Kaori Hisazaki1, Yasuhiko Mitsuke1,2, Taketoshi Yamazaki1, Hiroshi Tada1.   

Abstract

To estimate the associations between dysnatraemia and inflammatory marker [including interleukin-6 (IL-6)], and tissue remodelling marker [matrix metalloproteinase (MMP)-9 and tissue inhibitor of MMP (TIMP)-1], the pulmonary capillary wedge pressure (PCWP), mean pulmonary artery pressure (PAP), and left ventricular end-diastolic pressure (EDP), and the prognostic relevance in patients with heart failure. The serum sodium level and circulating levels of IL-6, MMP-9, and TIMP-1 were measured in 173 heart failure patients. Dual heart catheterisation was performed to measure PCWP, mean PAP, and EDP. All-cause mortality was assessed during the follow-up period (mean 88 ± 49 months). Restricted cubic spline (RCS) regression showed a U-shaped association of serum sodium level with TIMP-1, with the lowest values in the 138-140 mmol/L range (P for effect = 0.042, P for non-linearity = 0.017). IL-6 and MMP-9 levels showed non-significant associations with serum sodium level. U-shaped associations of serum sodium level with PCWP (P for effect = 0.004, P for non-linearity = 0.001) and mean PAP (P for effect = 0.042, P for non-linearity = 0.017) were found with the RCS regression model. The random forest model revealed that TIMP-1, MMP-9, and IL-6 were important predictors for serum sodium levels. Restricted cubic spline Cox regressions demonstrated that TIMP-1 levels indicated a U-shaped, concaved, non-linear association with all-cause mortality (P for effect = 0.011, P for non-linearity = 0.022). Dysnatraemia is an index of TIMP-1 aggravation and elevated PCWP, mean PAP; hence, it is associated with worsening all-cause mortality.Clinical Trial Registration: UMIN000023840.
© 2021. Springer Japan KK, part of Springer Nature.

Entities:  

Keywords:  All-cause mortality; Chronic heart failure; Hyponatraemia; Interleukin-6; Matrix metalloproteinase-9; Tissue inhibitors of matrix metalloproteinase-1

Mesh:

Substances:

Year:  2022        PMID: 35031882     DOI: 10.1007/s00380-021-02004-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  24 in total

Review 1.  Hyponatremia in patients with heart failure.

Authors:  Leonardo De Luca; Liviu Klein; James E Udelson; Cesare Orlandi; Gennaro Sardella; Francesco Fedele; Mihai Gheorghiade
Journal:  Am J Cardiol       Date:  2005-10-05       Impact factor: 2.778

Review 2.  Hyponatremia in acute decompensated heart failure: depletion versus dilution.

Authors:  Frederik H Verbrugge; Paul Steels; Lars Grieten; Petra Nijst; W H Wilson Tang; Wilfried Mullens
Journal:  J Am Coll Cardiol       Date:  2015-02-10       Impact factor: 24.094

3.  Prognostic importance of sodium level trajectory in acute heart failure.

Authors:  Yuya Matsue; Kenji Yoshioka; Makoto Suzuki; Sho Torii; Satoshi Yamaguchi; Seiji Fukamizu; Yuichi Ono; Hiroyuki Fujii; Takeshi Kitai; Toshihiko Nishioka; Kaoru Sugi; Yuko Onishi; Makoto Noda; Nobuyuki Kagiyama; Yasuhiro Satoh; Kazuki Yoshida; Steven R Goldsmith
Journal:  Heart Vessels       Date:  2017-07-11       Impact factor: 2.037

4.  Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.

Authors:  Mihai Gheorghiade; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Barry H Greenberg; Christopher M O'Connor; Lilin She; Clyde W Yancy; James Young; Gregg C Fonarow
Journal:  Eur Heart J       Date:  2007-02-19       Impact factor: 29.983

5.  Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure.

Authors:  Csaba P Kovesdy; Evan H Lott; Jun Ling Lu; Sandra M Malakauskas; Jennie Z Ma; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  Circulation       Date:  2012-01-05       Impact factor: 29.690

6.  Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension.

Authors:  Paul R Forfia; Stephen C Mathai; Micah R Fisher; Traci Housten-Harris; Anna R Hemnes; Hunter C Champion; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2008-03-20       Impact factor: 21.405

7.  Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.

Authors:  Mihai Gheorghiade; Joseph S Rossi; William Cotts; David D Shin; Anne S Hellkamp; Ileana L Piña; Gregg C Fonarow; Teresa DeMarco; Daniel F Pauly; Joseph Rogers; Thomas G DiSalvo; Javed Butler; Joshua M Hare; Gary S Francis; Wendy Gattis Stough; Christopher M O'Connor
Journal:  Arch Intern Med       Date:  2007-10-08

8.  Low-Normal Serum Sodium and Heart Failure-Related Events in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction.

Authors:  Hiroaki Kusaka; Seigo Sugiyama; Eiichiro Yamamoto; Eiichi Akiyama; Yasushi Matsuzawa; Yoshihiro Hirata; Koichiro Fujisue; Hirofumi Kurokawa; Junichi Matsubara; Koichi Sugamura; Hirofumi Maeda; Hideaki Jinnouchi; Kunihiko Matsui; Hisao Ogawa
Journal:  Circ J       Date:  2015-12-03       Impact factor: 2.993

9.  Hyponatremia at discharge as a predictor of 12-month clinical outcomes in hospital survivors after acute myocardial infarction.

Authors:  Myung Hwan Bae; Jae Hee Kim; Se Yong Jang; Sun Hee Park; Jang Hoon Lee; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung Chull Chae
Journal:  Heart Vessels       Date:  2016-06-02       Impact factor: 2.037

10.  Hyponatremia and Worsening Sodium Levels Are Associated With Long-Term Outcome in Patients Hospitalized for Acute Heart Failure.

Authors:  Dai-Yin Lu; Hao-Min Cheng; Yu-Lun Cheng; Pai-Feng Hsu; Wei-Ming Huang; Chao-Yu Guo; Wen-Chung Yu; Chen-Huan Chen; Shih-Hsien Sung
Journal:  J Am Heart Assoc       Date:  2016-03-23       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.